DD vs STRO
Dupont De Nemours Inc (DD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DD and STRO stock pages for the full models.
Not investment advice.